肾结石管理市场、机会、成长动力、产业趋势分析与预测，2024-2032

2023年全球肾结石管理市场价值约26亿美元，预计2032年将成长至41亿美元左右，复合年增长率为5.1%。这种增长主要是由于肾结石患病率的增加、高復发率以及先进治疗技术解决方案的不断开发所推动的。由于人口老化和生活方式因素（例如高盐、蛋白质和草酸盐的饮食），肾结石在通过尿道时会引起严重疼痛，因此变得越来越常见。

肾结石管理涉及一系列旨在减少结石形成的医疗治疗、诊断工具和预防策略。市场按结石类型细分，其中以草酸钙结石最为普遍，占结石病例的 75-80%。 2023年，草酸钙细分市场创造了19亿美元的收入。这些结石的危险因子包括富含草酸盐的饮食，例如菠菜和坚果，以及高钙摄取量。

该市场的诊断包括腹部 X 光检查、CT 扫描、超音波、MRI 和静脉肾盂造影。 CT scans led the market in 2023, and their popularity is expected to continue growing, with a projected market value of USD 1.3 billion by 2032. The appeal of CT scans lies in their rapid, non-invasive nature, making them particularly useful in emergency设定.

肾结石的治疗方法包括体外震波碎石术（ESWL）、输尿管镜检查和经皮肾镜取石术（PCNL）。 2023年ESWL占据市场主导地位，占58.2%的市占率。这种非侵入性技术使用衝击波来分解结石，以便更容易通过，对草酸钙和尿酸等结石特别有效。

医院是肾结石管理市场最大的最终用户，到2023 年将产生13 亿美元的收入。肾结石管理市场的关键驱动力。

从地区来看，北美在 2023 年以 11 亿美元的价值引领市场。该地区肾结石的高盛行率归因于饮食和生活方式因素。此外，该地区先进的医疗基础设施支援全面的肾结石管理。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 全球肾结石盛行率和復发率不断上升
    • 输尿管镜技术的进步
    • 碎石手术的优惠报销
    • 倾向接受微创手术
    • 人们对整体肾臟健康的认识不断提高
  • 产业陷阱与挑战
    • 某些国家缺乏治疗意识
    • 碎石术的潜在长期不良影响
• 成长潜力分析
• 技术景观
• 未来市场趋势
• 监管环境
• 报销场景
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

• 主要趋势
• 草酸钙
• 磷酸钙
• 尿酸
• 鸟粪石
• 半胱胺酸

第 6 章：市场估计与预测：透过诊断，2021 - 2032

• 主要趋势
• 腹部 X 光检查
• 电脑断层扫描
• 超音波
• 腹部核磁共振检查
• 静脉肾盂造影
• 其他诊断

第 7 章：市场估计与预测：按处理方式，2021 - 2032

• 主要趋势
• 腹部 X 光检查
• 体外震波碎石术（ESWL）
• 输尿管镜检查
• 经皮肾镜取石术（PCNL）
• 其他治疗

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 专科诊所
• 门诊手术中心
• 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Allengers Medical Systems Ltd
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast A/S
• Cook Medical LLC
• DirexGroup
• Dornier MedTech
• EDAP TMS SA
• Elmed Medical Systems
• Karl Storz GmbH
• Medispec Ltd
• Olympus Corporation
• Richard Wolf GmbH
• Siemens Healthineers

The Global Kidney Stone Management Market was valued at approximately USD 2.6 billion in 2023 and is projected to grow to around USD 4.1 billion by 2032, with a CAGR of 5.1%. This growth is largely driven by the increasing prevalence of kidney stones, their high recurrence rates, and the ongoing development of advanced technological solutions for treatment. Kidney stones, which can cause significant pain as they move through the urinary tract, are becoming more common due to aging populations and lifestyle factors, such as diets high in salt, protein, and oxalates.

Kidney stone management involves a range of medical treatments, diagnostic tools, and preventative strategies aimed at reducing stone formation. The market is segmented by stone type, with calcium oxalate stones being the most prevalent, representing 75-80% of cases. In 2023, the calcium oxalate segment generated USD 1.9 billion in revenue. Risk factors for these stones include diets rich in oxalates, such as spinach and nuts, along with high calcium intake.

Diagnostics in this market include abdominal x-rays, CT scans, ultrasounds, MRIs, and intravenous pyelography. CT scans led the market in 2023, and their popularity is expected to continue growing, with a projected market value of USD 1.3 billion by 2032. The appeal of CT scans lies in their rapid, non-invasive nature, making them particularly useful in emergency settings.

Treatment methods for kidney stones include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL). ESWL dominated the market in 2023, accounting for 58.2% of the market share. This non-invasive technique uses shock waves to break down stones for easier passage and is especially effective for stones like calcium oxalate and uric acid.

Hospitals were the largest end use rs in the kidney stone management market, generating USD 1.3 billion in 2023. Hospitals are equipped to handle emergencies such as acute renal colic and offer advanced technologies, such as laser lithotripters and surgical robots, which are key drivers for this segment.

Regionally, North America led the market in 2023 with a value of USD 1.1 billion. The region's high prevalence of kidney stones is attributed to dietary and lifestyle factors. Additionally, the region's advanced healthcare infrastructure supports comprehensive kidney stone management.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence and recurrence rate of kidney stones globally
    • 3.2.1.2 Advancements in ureteroscopy technique
    • 3.2.1.3 Favourable reimbursement for lithotripsy procedures
    • 3.2.1.4 Inclination towards undergoing minimally invasive surgeries
    • 3.2.1.5 Rising awareness regarding overall kidney health
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of treatment awareness in certain countries
    • 3.2.2.2 Potential long-term adverse effects of lithotripsy
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Calcium oxalate
• 5.3 Calcium phosphate
• 5.4 Uric acid
• 5.5 Struvite
• 5.6 Cysteine

Chapter 6 Market Estimates and Forecast, By Diagnostics, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Abdominal x-ray
• 6.3 Computed tomography
• 6.4 Ultrasound
• 6.5 Abdominal MRI
• 6.6 Intravenous pyelography
• 6.7 Other diagnostics

Chapter 7 Market Estimates and Forecast, By Treatment, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Abdominal x-ray
• 7.3 Extracorporeal shock wave lithotripsy (ESWL)
• 7.4 Ureteroscopy
• 7.5 Percutaneous nephrolithotomy (PCNL)
• 7.6 Other treatments

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Allengers Medical Systems Ltd
• 10.2 Becton, Dickinson and Company
• 10.3 Boston Scientific Corporation
• 10.4 Coloplast A/S
• 10.5 Cook Medical LLC
• 10.6 DirexGroup
• 10.7 Dornier MedTech
• 10.8 EDAP TMS S.A
• 10.9 Elmed Medical Systems
• 10.10 Karl Storz GmbH
• 10.11 Medispec Ltd
• 10.12 Olympus Corporation
• 10.13 Richard Wolf GmbH
• 10.14 Siemens Healthineers